E-cigarettes with a mint flavor are more likely to deteriorate lung health.

Published Date: 24 Apr 2023

Adding mint flavor to e-cigarette liquids increases the amount of vapour particles produced and is linked, according to a recent study published in Respiratory Research.

Read Full News

Latest News

PAP Therapy May Reduce Pulmonary Pressures in Sleep Apnea

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon to Stock Lilly's New Weight-loss Pill At US Kiosks, Offer Same-day Delivery

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Treprostinil Can Slow Lung Decline in Pulmonary Fibrosis

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

Can Past Sleep Problems Hinder Smoking Cessation?

People with existing sleep problems may find it harder to quit smoking when seeking help to stop using tobacco.

Fan-to-Face Therapy May Ease Breathlessness in Lung Disease

Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training sessions and improves training tolerability in patients with chronic lung disease.

Preterm BPD May Reduce Exercise Capacity at School Age

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Latest News

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

People with existing sleep problems may find it harder to quit smoking when seeking help to stop using tobacco.

Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training sessions and improves training tolerability in patients with chronic lung disease.

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

News All Time

New CHEST Recommendations Guide Biologic Use for Severe Asthma

New CHEST Recommendations Guide Biologic Use for Severe Asthma

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

Recommended News For You

Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer

Why alarm is easing over a rise in pancreatic cancer among the young

Mental health risk persists years after cancer diagnosis

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

In early dementia, SSRIs enhance cognition and major depression.

Recommended Articles For You

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v 

Radiation Oncology Advances: Guidelines, Trials, Digital Tools & Education 

Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring 

First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

After two years, a significant left nasal obstruction was finally diagnosed.

2.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

3.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

4.

AI could help improve early detection of interval breast cancers

5.

Older Adults With Advanced Cancer Prioritize Quality of Life

1.

Managing Hematoma: A Guide to Prevention and Treatment

2.

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

3.

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51%

4.

Breaking Down the Different Types of Lymphoma: What You Need to Know 

5.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

2.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

3.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot